We are live on
!
Find out more
GS
Gagnon Securities Portfolio holdings
AUM
$519M
Turnover
11.24%
1-Year Est. Return
44.91%
This Fund
S&P 500
This Quarter
Est. Return
-22.02%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$477M
AUM Growth
-$136M
(-22%)
Cap. Flow
+$15.9M
Cap. Flow
% of AUM
3.33%
Top 10 Holdings %
Top 10 Hldgs %
44.57%
Holding
110
New
7
Increased
59
Reduced
28
Closed
9
Avg Time Held
3.4
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yext
YEXT
|
+$6.12M |
| 2 |
BioLife Solutions
BLFS
|
+$2.82M |
| 3 |
SecureWorks Corp Class A Common Stock
SCWX
|
+$2.38M |
| 4 |
Protolabs
PRLB
|
+$2.36M |
| 5 |
CareDx
CDNA
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alpha and Omega Semiconductor
AOSL
|
+$2.74M |
| 2 |
ExxonMobil
XOM
|
+$1.45M |
| 3 |
Pacira BioSciences
PCRX
|
+$1.08M |
| 4 |
The Ensign Group
ENSG
|
+$951K |
| 5 |
Navigator Holdings
NVGS
|
+$490K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.08% |
| 2 | Technology | 23.78% |
| 3 | Industrials | 15.19% |
| 4 | Energy | 10.52% |
| 5 | Consumer Discretionary | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Alphabet (Google) Class A
GOOGL
$4.27T
| $338K | 0.07% |
3,100
| – | – |
2021 Q1
5 quarters
|
|
77
DELISTED
Warner Bros
WBD
| $334K | 0.07% |
+24,862
| New | +$461K |
2022 Q2
0 quarters
|
|
78
Redhill Biopharma
RDHL
$4.44M
| $327K | 0.07% |
375
+8
| +2% | +$11K |
2019 Q4
10 quarters
|
|
79
PayPal
PYPL
$48.9B
| $289K | 0.06% |
4,141
+32
| +0.8% | +$2.78K |
2017 Q3
19 quarters
|
|
80
DELISTED
MODEL N, INC.
MODN
| $278K | 0.06% |
10,862
+1
| +0% | +$25 |
2021 Q4
2 quarters
|
|
81
RingCentral
RNG
$6.68B
| $258K | 0.05% |
4,943
+1,949
| +65% | +$148K |
2021 Q4
2 quarters
|
|
82
Micron Technology
MU
$1.05T
| $254K | 0.05% |
4,592
| – | – |
2020 Q4
6 quarters
|
|
83
Viavi Solutions
VIAV
$9.05B
| $253K | 0.05% |
19,086
+97
| +0.5% | +$1.4K |
2020 Q1
9 quarters
|
|
84
Core Laboratories
CLB
$449M
| $221K | 0.05% |
11,174
+163
| +1% | +$4.33K |
2020 Q3
7 quarters
|
|
|
WGSWW
85
DELISTED
GeneDx Holdings Warrant
WGSWW
| $216K | 0.05% |
665,722
+5,082
| +0.8% | +$2.07K |
2021 Q2
4 quarters
|
|
86
Onto Innovation
ONTO
$11.4B
| $212K | 0.04% |
3,033
+21
| +0.7% | +$1.55K |
2019 Q4
10 quarters
|
|
87
Commault Systems
CVLT
$6.59B
| $209K | 0.04% |
3,324
+8
| +0.2% | +$497 |
2022 Q1
1 quarter
|
|
88
Boston Beer
SAM
$1.84B
| $201K | 0.04% |
+665
| New | +$231K |
2022 Q2
0 quarters
|
|
89
DELISTED
LivePerson
LPSN
| $200K | 0.04% |
944
| – | – |
2013 Q2
36 quarters
|
|
90
GoodRx Holdings
GDRX
$1.19B
| $194K | 0.04% |
32,693
+11,224
| +52% | +$125K |
2021 Q1
5 quarters
|
|
|
SLGCW
91
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $137K | 0.03% |
+180,608
| New | +$205K |
2022 Q2
0 quarters
|
|
92
DELISTED
T2 Biosystems, Inc
TTOO
| $123K | 0.03% |
152
| – | – |
2017 Q3
19 quarters
|
|
93
Viatris
VTRS
$20.9B
| $106K | 0.02% |
+10,129
| New | +$111K |
2022 Q2
0 quarters
|
|
|
APTO
94
DELISTED
Aptose Biosciences, Inc.
APTO
| $38K | 0.01% |
115
| – | – |
2020 Q2
8 quarters
|
|
95
Etsy
ETSY
$8.19B
| – | – |
-2,052
| Closed | -$255K | – |
|
96
Meta Platforms (Facebook)
META
$1.88T
| – | – |
-1,068
| Closed | -$237K | – |
|
97
Microsoft
MSFT
$4.01T
| – | – |
-662
| Closed | -$204K | – |
|
98
NVIDIA
NVDA
$5.25T
| – | – |
-11,890
| Closed | -$324K | – |
|
99
Roblox
RBLX
$36.5B
| – | – |
-4,868
| Closed | -$225K | – |
|
100
Bristow Group
VTOL
$1.12B
| – | – |
-7,508
| Closed | -$278K | – |
|
Similar funds
WS
MWC
MWM
CFG
PDIP
VP
CFA
SWM
Gagnon Securities's Q2 2022 Portfolio in Review
As of Q2 2022, Gagnon Securities held 110 positions worth $477M, down 22% from $613M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Gagnon Securities deployed $15.9M of net new capital in Q2 2022, opening 7 new positions and adding to 59 existing holdings. Its largest new stake was Heron Therapeutics: 367,514 shares worth $1.02M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Alpha and Omega Semiconductor, an estimated $2.74M trimmed.
- Gagnon Securities's largest Q2 2022 buy was Heron Therapeutics: 367,514 shares worth $1.02M.
- Gagnon Securities added most to Yext in Q2 2022, an estimated $6.12M increase.
- Gagnon Securities's biggest Q2 2022 reduction was Alpha and Omega Semiconductor, cutting an estimated $2.74M.
- Gagnon Securities fully exited NVIDIA in Q2 2022, selling an estimated $324K.
- Gagnon Securities's ten largest holdings make up 45% of its $477M portfolio in Q2 2022.
- Gagnon Securities opened 7 new positions and closed 9 in Q2 2022.
- Gagnon Securities's portfolio value fell 22% quarter-over-quarter to $477M.
Based on Gagnon Securities's 13F filing for Q2 2022, filed 1 Aug 2022.